Mélina Chasle

Title: Innovations by Inventor Mélina Chasle

Introduction

Mélina Chasle is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of virology, particularly in the development of stable formulations for vaccinia virus. With a total of 2 patents, Chasle's work is paving the way for advancements in vaccine technology.

Latest Patents

Chasle's latest patents include innovative formulations aimed at improving the stability and efficacy of poxvirus vaccines. The first patent, titled "Stable liquid vaccinia virus formulations," focuses on creating liquid formulations of vaccinia virus that remain stable during storage. This formulation includes a poxvirus, a pharmaceutically acceptable buffer, a monovalent salt, a disaccharide or sugar alcohol, and a chelating agent, with a pH range between 6.5 and 8.5.

The second patent, "Virus-containing formulation and use thereof," describes a formulation that comprises at least one virus-based material, a polymer, sugar, amino acids, and pharmaceutical salts, including phosphate salts. This formulation is particularly suitable for freeze-drying and can be reconstituted for administration to patients, making it useful for vaccines targeting cancers, infectious diseases, and autoimmune disorders.

Career Highlights

Mélina Chasle is currently associated with Transgene S.A., where he continues to innovate in the field of vaccine development. His work is characterized by a strong focus on creating formulations that enhance the stability and effectiveness of viral vaccines.

Collaborations

Chasle collaborates with Claude Sene, contributing to the advancement of their shared goals in vaccine research and development.

Conclusion

Mélina Chasle's contributions to the field of virology through his innovative patents are significant. His work at Transgene S.A. exemplifies the importance of research in developing effective vaccines for various diseases.